Massachusetts Institute of Technology (MIT) - Laboratory for Financial Engineering, Novartis, Novartis, Novartis, Novartis, Novartis, Novartis, Novartis, Genomics Institute of the Novartis Research Foundation, Genomics Institute of the Novartis Research Foundation, Genomics Institute of the Novartis Research Foundation, Genomics Institute of the Novartis Research Foundation and Massachusetts Institute of Technology (MIT) - Laboratory for Financial Engineering

University of North Carolina (UNC) at Chapel Hill - School of Medicine, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Curriculum in Genetics and Molecular Biology, Broad Institute of MIT and Harvard, Broad Institute of MIT and Harvard, Broad Institute of MIT and Harvard, Broad Institute of MIT and Harvard, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Oral and Craniofacial Biomedicine PhD Program, Oslo University Hospital, University of North Carolina (UNC) at Chapel Hill - Department of Nutrition, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) at Chapel Hill - Curriculum in Genetics and Molecular Biology, Translational Genomic Research Institute - Cancer and Cell Biology Division, Translational Genomic Research Institute - Cancer and Cell Biology Division, Genomics Institute of the Novartis Research Foundation, Genomics Institute of the Novartis Research Foundation, Genomics Institute of the Novartis Research Foundation, University of North Carolina (UNC) at Chapel Hill - Department of Pharmacology, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center, Translational Genomic Research Institute - Cancer and Cell Biology Division, Broad Institute of MIT and Harvard, Broad Institute of MIT and Harvard, University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center and University of North Carolina (UNC) at Chapel Hill - Lineberger Comprehensive Cancer Center